DENDRITIC CELL ASGPR TARGETING IMMUNOTHERAPEUTICS FOR MULTIPLE SCLEROSIS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160296609A1
SERIAL NO

14901617

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Methods and compositions for treating multiple sclerosis using dendritic cell anti-ASGPR antibodies fused to myelin basic protein or myelin oligodendrocyte glycoprotein provided.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BAYLOR RESEARCH INSTITUTE3434 LIVE OAK STREET DALLAS TX 75204

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Oh, SangKon Baltimore, US 47 553
Zurawski, Gerard Midothian, US 87 1622

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation